[{"Assets_0_Q3_USD":1760710000.0,"CommonStockSharesOutstanding_0_Q3_shares":155363980.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":38768000.0,"StockholdersEquity_0_Q3_USD":1150715000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":248720000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":778512000.0,"Ticker":"ALKS","CIK":"1520262","name":"ALKERMES PLC.","OfficialName":"Alkermes plc Ordinary Shares","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4612884468.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181023"}]